From the Journals

Oral tecovirimat for smallpox shows efficacy in animals, safety in humans


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

Dr. Grosenbach and his coauthors reported a disclosure related to Biomedical Advanced Research and Development Authority (BARDA), grants from NIH during the conduct of the study, and personal fees from SIGA Technologies outside the submitted work.

SOURCE: Grosenbach DW et al. N Engl J Med. 2018 Jul 5;379(1):44-53.

Pages

Recommended Reading

TB in 2017: Good news and bad news
MDedge Family Medicine
Are higher rifampin doses for pulmonary TB more effective?
MDedge Family Medicine
MDedge Daily News: Why low-calorie sucralose may fuel weight gain
MDedge Family Medicine
Zika virus: Sexual contact risk may be limited to short window
MDedge Family Medicine
Piperacillin-tazobactam tripled risk of death for patients with cephalosporin-resistant septicemia
MDedge Family Medicine
FDA advisory committee votes to recommend first once-daily aminoglycoside antibiotic
MDedge Family Medicine
Don’t shorten therapy for older, sicker cellulitis patients
MDedge Family Medicine
Blood type A linked to more-severe diarrhea
MDedge Family Medicine
NIH launches early Ebola treatment trial
MDedge Family Medicine
FDA issues Ebola preparedness statement
MDedge Family Medicine